Clinical Trial Update: Hepar-P Study to Evaluate the Safety and Efficacy of a Standardised Extract of Phyllanthus Niruri for the Treatment of Non-alcoholic Fatty Liver Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the safety and efficacy of a standardized extract of Phyllanthus niruri (Hepar-P) for treating non-alcoholic fatty liver …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• Hepar-P (Phyllanthus niruri extract)

Snippet

Sponsor: Nova Laboratories Sdn Bhd | Conditions: Non-alcoholic Fatty Liver Disease | Phase 2 | Status: UNKNOWN